Overview of Mainstream Perp DEXs: Hyperliquid's holdings remain sluggish, trading volume rebounds to $7.5 billion

GateUser-6433627c · 2026-02-12T10:32:57+00:00

Data from February 12th shows that mainstream Perp DEX trading volume is recovering, with Hyperliquid leading at $7.5 billion in trading volume, but open interest remains sluggish. Other platforms' trading volumes are Aster $3.64 billion, EdgeX $3.51 billion, Lighter $2.3 billion, etc. Overall volatility remains stable.

GateUser-6433627c

2026-02-12 10:32:57

Abstract generation in progress

On February 12, according to DefiLlama data, trading volumes on mainstream Perp DEXs generally rebounded, but platform holdings remain low, with overall volatility stable. Among them, Hyperliquid maintained the leading trading volume, reaching $7.5 billion in a single day, a significant increase from yesterday; however, its holdings still show no obvious rebound. The current main Perp DEX trading volumes are as follows: Hyperliquid’s 24-hour trading volume is approximately $7.53 billion, TVL is about $4.23 billion, and open interest is around $4.9 billion; Aster’s 24-hour trading volume is approximately $3.64 billion, TVL is about $1.08 billion, and open interest is around $1.82 billion; EdgeX’s 24-hour trading volume is approximately $3.51 billion, TVL is about $1.85 billion, and open interest is around $1.02 billion; Lighter’s 24-hour trading volume is approximately $2.3 billion, TVL is about $922 million, and open interest is around $722 million; Grvt’s 24-hour trading volume is approximately $1.84 billion, TVL is about $89.26 million, and open interest is around $386 million; Pacifica’s 24-hour trading volume is approximately $760 million, TVL is about $37.87 million, and open interest is around $48.85 million.

HYPE1,37%

ASTER-2,8%

LIT-4,75%

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.